Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | PARP1 | P09874 | 1/20 | 0.46 |
| ▸ | SLC5A2 | P31639 | 2/20 | 0.40 |
| ▸ | SLC5A1 | P13866 | 1/20 | 0.40 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.39 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.39 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.39 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.39 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | DRD3 | P35462 | 3/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | MGLL | Q99685 | 1/20 | 0.36 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15281735 | 0.85 | DRD3 (0.48) | TSHRPARP1CHRM2CHRM3CHRM4 | |
| SCHEMBL30988806 | 0.83 | SLC5A2 (0.36) | TSHRPARP1SLC5A2SLC5A1SIGMAR1 | |
| SCHEMBL29256520 | 0.83 | SLC5A2 (0.36) | TSHRPARP1SLC5A2SLC5A1SIGMAR1 | |
| SCHEMBL4332736 | 0.81 | TSHR (0.48) | TSHRPARP1CHRM2CHRM3CHRM4 | |
| SCHEMBL28261596 | 0.81 | PARP1 (0.50) | TSHRPARP1 | |
| SCHEMBL5271487 | 0.80 | SPHK2 (0.52) | SLC6A2SLC6A4 | |
| SCHEMBL14753778 | 0.79 | TSHR (0.39) | TSHRPARP1CHRM2CHRM3CHRM4 | |
| SCHEMBL11941052 | 0.79 | SMN1; SMN2 (0.49) | SLC5A2SLC5A1CHRM2CHRM3CHRM4 | |
| SCHEMBL19101551 | 0.79 | TSHR (0.47) | TSHRPARP1CHRM2CHRM3CHRM4 | |
| SCHEMBL21974861 | 0.79 | TSHR (0.67) | TSHRPARP1CHRM2CHRM3CHRM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118340754-B | Compound for treating heart failure and related diseases and application thereof | 源道医药(苏州)有限公司 | 2025-03-11 | — | — | CN | disclosed |
| CN-119490387-A | Compounds for the treatment of pain-related diseases | 源道医药(苏州)有限公司 | 2025-02-21 | — | — | CN | disclosed |
| CN-118340754-A | Compound for treating heart failure and related diseases and application thereof | 源道医药(苏州)有限公司 | 2024-07-16 | — | — | CN | disclosed |
| EP-3906969-A1 | ANTIHYPERTENSIVE POLYOL COMPOUND AND DERIVATIVE THEREOF | East China University of Science and Technology (CN) | 2021-11-10 | — | — | EP | disclosed |
| WO-2020249117-A1 | ANTIHYPERTENSIVE POLYOL COMPOUND AND DERIVATIVE THEREOF | 华东理工大学 | 2020-12-17 | — | — | WO | disclosed |
| US-9321871-B2 | Water insoluble copolymer including pendant aryl epoxide groups | DOW GLOBAL TECHNOLOGIES LLC | 2016-04-26 | — | — | US | disclosed |
| US-20150259456-A1 | WATER INSOLUBLE COPOLYMER INCLUDING PENDANT ARYL EPOXIDE GROUPS | ROHM AND HAAS CHEMICALS LLC | 2015-09-17 | — | — | US | disclosed |
| US-20150238597-A1 | CARBOHYDRATE-GLYCOLIPID CONJUGATE VACCINES | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2015-08-27 | — | — | US | disclosed |
| US-9080046-B2 | Epoxybenzyl-terminated poly(arylene ether)s, method for preparation thereof, and curable compositions comprising same | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2015-07-14 | — | — | US | disclosed |
| US-9080046-B2 | Epoxybenzyl-terminated poly(arylene ether)s, method for preparation thereof, and curable compositions comprising same | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2015-07-14 | — | — | US | disclosed |
| US-20140058014-A1 | EPOXYBENZYL-TERMINATED POLY(ARYLENE ETHER)S, METHOD FOR PREPARATION THEREOF, AND CURABLE COMPOSITIONS COMPRISING SAME | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2014-02-27 | — | — | US | disclosed |
| US-20140058014-A1 | EPOXYBENZYL-TERMINATED POLY(ARYLENE ETHER)S, METHOD FOR PREPARATION THEREOF, AND CURABLE COMPOSITIONS COMPRISING SAME | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2014-02-27 | — | — | US | disclosed |
| WO-2013032739-A2 | EPOXYBENZYL-TERMINATED POLY(ARYLENE ETHER)S, METHOD FOR PREPARATION THEREOF, AND CURABLE COMPOSITIONS COMPRISING SAME | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2013-03-07 | — | — | WO | disclosed |
| US-20130059127-A1 | EPOXYBENZYL-TERMINATED POLY(ARYLENE ETHER)S, METHOD FOR PREPARATION THEREOF, AND CURABLE COMPOSITIONS COMPRISING SAME | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2013-03-07 | — | — | US | disclosed |
| US-20130059127-A1 | EPOXYBENZYL-TERMINATED POLY(ARYLENE ETHER)S, METHOD FOR PREPARATION THEREOF, AND CURABLE COMPOSITIONS COMPRISING SAME | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2013-03-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150238597-A1 | CARBOHYDRATE-GLYCOLIPID CONJUGATE VACCINES | STT3B, STT3A, DDOST | TSHR 3638/4885PARP1 4184/4885SLC5A2 1072/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.